Influenza A virus H1 hemagglutinin receptor-binding domain (H1 HA RBD)

The H1 hemagglutinin receptor-binding domain (RBD) is a critical structural component of the influenza A virus hemagglutinin (HA) protein, located within the HA1 subunit's distal globular head. Its primary biological role is to mediate the initial attachment of the virus to host cells by recognizing and binding to specific sialic acid receptors on the surface of respiratory epithelial cells (Skehel & Wiley, 2000). As the major surface antigen, the RBD is the primary target for neutralizing antibodies elicited by both natural infection and vaccination; these antibodies prevent infection by sterically hindering the virus's ability to dock with host receptors (Knossow & Skehel, 2006). However, the RBD is highly susceptible to antigenic drift, where point mutations in the antibody-binding sites allow the virus to escape host immunity, necessitating the annual reformulation of influenza vaccines (Webster et al., 1992). In vaccine development, the H1 HA RBD from specific vaccine strains is used to prime the immune system to recognize circulating H1N1 viruses. Beyond vaccines, the RBD is a focal point for the development of monoclonal antibodies and small-molecule entry inhibitors designed to provide passive immunity or therapeutic treatment during outbreaks (Whittle et al., 2011).

Other names

H1 HA1 subunitHA globular headH1N1 hemagglutininHemagglutinin receptor-binding site

Neutralization of viral infectivity by inducing or providing antibodies that block the interaction between the viral hemagglutinin globular head and host cell sialic acid receptors.